楚天转债盘中下跌2.3%报127.886元/张，成交额2564.88万元，转股溢价率21.04%

Group 1 - The core viewpoint of the news is the performance and characteristics of Chutian Convertible Bonds, which have seen a decline in market price and a notable conversion premium rate [1] - Chutian Convertible Bonds have a credit rating of "AA" and a maturity period of 6 years with increasing interest rates from 0.30% in the first year to 2.00% in the sixth year [1] - The conversion price for the bonds is set at 8.0 yuan, with the conversion period starting on August 6, 2024 [1] Group 2 - Chutian Technology Co., Ltd. is a leading enterprise in the Chinese pharmaceutical equipment industry, established in 2000, and is recognized globally [2] - The company specializes in pharmaceutical equipment and comprehensive technical solutions, and is a pioneer in the research and development of smart pharmaceutical factories [2] - For the first half of 2025, Chutian Technology reported a revenue of 2.4174 billion yuan, a year-on-year decrease of 14.55%, while the net profit attributable to shareholders was -12.3 million yuan, an increase of 85.11% year-on-year [2] - As of June 2025, the concentration of shareholding in Chutian Technology is relatively dispersed, with the top ten shareholders holding a combined 45.16% of shares [2]